CBD and Cancer: What the Research and the FDA Say
Can CBD treat cancer? The National Cancer Institute says the FDA “has not approved Cannabis or cannabinoids for use as a cancer treatment,” and that cannabis is not approved for any cancer-related symptom or side effect of cancer therapy. Most research on CBD and cancer comes from lab and animal studies, with only a few small studies in people.
Cannabis has a long medical history. The National Cancer Institute notes that its medicinal use dates back at least 3,000 years and that it entered Western medicine in 1839; the 1937 Marihuana Tax Act taxed it, and in 1942 it was removed from the U.S. Pharmacopoeia. Today a growing number of states, territories and the District of Columbia allow medical or adult use, and the FDA warns that CBD can cause liver injury and can affect how other drugs you take work.

What Is Cancer?
Rather than being one disease, cancer is the name for more than 100 diseases, caused by both genetic and outside factors. Normally, cells grow old and die, and the body makes new cells to replace them. When cancer develops, abnormal cells, which include old and damaged cells, survive. Some of these cells keep dividing without stopping and can spread into nearby tissue, forming growths called tumors that can start almost anywhere in the body.
Cancerous tumors can also travel to distant places in the body, which is one reason treatment matters. Treatment depends on the kind of cancer, though many cancers are treated with the same main methods. Many cancer treatments also cause side effects of their own, such as nausea and loss of appetite.
What Does Cancer Research Show About Cannabis and CBD?
Cannabis has several compounds known as cannabinoids. Two of these cannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD), are studied most often, and cancer research is no exception: THC slowed tumors in some mouse studies but sped tumor growth in others, so researchers are also studying CBD, which is not intoxicating.
Only a few small human studies exist, mostly in brain tumors, so most evidence for CBD still comes from lab and animal studies, which have looked at these questions:
- Antitumor effects
- Antiemetic effects
- Appetite stimulation
- Analgesia
- Anxiety and sleep
Antitumor Effects
In a lab study of breast cancer cell lines, CBD induced programmed cell death in both estrogen receptor-positive and estrogen receptor-negative cells while having little effect on non-cancerous breast cells, the National Cancer Institute reports. A 2011 study found that CBD reduced breast cancer cell growth, invasion and spread in lab and animal tests.
In another study, CBD showed a chemopreventive effect in mouse models of colorectal cancer. In colorectal cancer cells grown in the lab, CBD also protected DNA from oxidative damage, increased endocannabinoid levels, and reduced cell proliferation. These are cell and mouse results, not evidence that CBD works against cancer in people.
Antiemetic Effects
In a 2004 study in house musk shrews, THC suppressed vomiting more at higher doses, while CBD suppressed it at low doses and made it worse at high doses.
Appetite Stimulation
Nausea from cancer and from its treatment can make it hard for patients to keep a healthy weight. CBD alone has not been shown to increase appetite; the appetite evidence is for THC and dronabinol, and in one large trial megestrol acetate worked better than oral THC.
Analgesia
Pain can come from cancer itself and from its treatment. Cannabis has a long history of use for pain, but trials in cancer pain are mixed. A 2010 trial found a THC and CBD extract eased cancer pain more than placebo, but two later phase 3 trials of the same spray did not.
Anxiety and Sleep
Anxiety and sleeplessness often accompany cancer. A 2019 case series looked at anxiety and sleep scores in 72 adults taking CBD at a psychiatric clinic, not cancer patients; anxiety scores fell in most, while sleep gains were less steady.
CBD is not approved for any cancer use, and it can change how other medicines work, so tell your oncology team about any CBD product you use or are considering. CBD also has side effects of its own, listed below.

What Are the Side Effects of CBD?
CBD is not harmless, even though it does not cause a high. The FDA lists these possible harms and side effects of CBD, among others:
- Liver injury
- Interactions with other medicines
- Drowsiness, especially with alcohol or sedatives
- Diarrhea and decreased appetite
- Changes in mood, such as irritability and agitation
Is There a CBD Dose for Cancer?
No. The FDA has not approved CBD for any cancer use, so there is no FDA-established CBD dose for cancer or its symptoms, and this post gives none. Florida requires hemp extract sold in the state to have an independent lab certificate of analysis, and our guide to CBD in Florida explains what that certificate shows. Any question about CBD during cancer care belongs with your oncology team.
The one FDA-approved CBD drug, Epidiolex, is approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex, and its label calls for liver blood tests before treatment starts because of the risk of liver injury. None of that makes CBD a cancer treatment.
Inhaling cannabis raises its own concerns, and CDC warns that smoked cannabis, however it is smoked, can harm lung tissues.
The Takeaway
Whether CBD has any role in cancer care still needs research in people. The National Cancer Institute says the FDA has not approved cannabis or cannabinoids as a cancer treatment, and that two cannabinoids, dronabinol and nabilone, are approved for nausea and vomiting caused by chemotherapy in patients who have not responded to antiemetic therapy. Neither drug is CBD. During cancer treatment, discuss every option, including any cannabis or CBD product, with your oncology team.
Last updated October 15, 2026 by the Dr. Green Relief Editorial Team.
Medical review
Medically reviewed by Achilles Kalnoky, M.D.
Reviewed on .
He is licensed in Florida as a medical doctor, license ME115088, which you can check on the Florida Department of Health license lookup.
His review covers the medical statements in this post and the sources cited for them.
Sources
- National Cancer Institute. Cannabis and Cannabinoids (PDQ), Patient Version
- National Cancer Institute. Cannabis and Cannabinoids (PDQ), Health Professional Version
- National Cancer Institute. What Is Cancer?
- FDA. What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD
- FDA. FDA and Cannabis: Research and Drug Approval Process
- DailyMed. Epidiolex (cannabidiol) oral solution, label
- CDC. Cannabis and Lung Health
- Florida Statutes, s. 581.217 (2026), State hemp program (Florida Senate)
- McAllister SD, et al. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat (PMC)
- Aviello G, et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med. 2012 (PubMed)
- Parker LA, et al. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology. 2004 (PubMed)
- Johnson JR, et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010 (PubMed)
- Fallon MT, et al. Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy. Br J Pain. 2017 (PubMed)
- Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series. Perm J. 2019 (PubMed)



